EUVIMEDScopri EUVIMED
MetaanalyseSystematische ÜbersichtOpen access

Clinical Efficacy of Mobile App–Based, Self-Directed Pulmonary Rehabilitation for Patients With Chronic Obstructive Pulmonary Disease: Systematic Review and Meta-Analysis

Klinische Wirksamkeit mobiler App-basierter, selbst gesteuerter pulmonaler Rehabilitation bei Patient:innen mit chronisch obstruktiver Lungenerkrankung: systematische Übersicht und Metaanalyse

Chiwook Chung iD, Jong Won Lee iD, Sei Won Lee iD, Min-Woo Jo iD

JMIR mHealth and uHealth · 2024-01-04 · 12 · e41753-e41753

DOI: 10.2196/41753 ↗

Auf einen Blick

10 Studien zeigen insgesamt günstige Ergebnisse für mobile App-basierte pulmonale Rehabilitation bei COPD; statistisch signifikant war nur der CAT-Score. Im Vergleich zur konventionellen Zentrumstherapie waren die übrigen Effekte nicht signifikant.

Fragestellung

Wie wirksam ist mobile App-basierte pulmonale Rehabilitation im Vergleich zur konventionellen, zentrumsbasierten pulmonalen Rehabilitation bei COPD?

Methode

Systematische Übersichtsarbeit und Metaanalyse randomisierter kontrollierter Studien; Suche in PubMed, Embase, Cochrane und CINAHL von Januar 2007 bis Juni 2023.

Ergebnisse

10 Studien in der Übersichtsarbeit, 9 in der Metaanalyse; 1.050 Teilnehmende. 6MWD: MD 9,52 (95 %-KI −3,05 bis 22,08 m); CAT: MD −1,29 (95 %-KI −2,39 bis −0,20); mMRC: MD −0,08 (95 %-KI −0,29 bis 0,13); SGRQ: MD −3,62 (95 %-KI −9,62 bis 2,38); Hospitalisierung: RR 0,65 (95 %-KI 0,27–1,53).

Einschränkungen

Unterschiede in Ausgangsmerkmalen, Smartphone-Apps, Interventionen und Studienergebnissen zwischen den eingeschlossenen Studien.

Schlussfolgerung der Autor:innen

Die Autor:innen berichten, dass mobile App-basierte pulmonale Rehabilitation im Vergleich zur konventionellen pulmonalen Rehabilitation günstige Ergebnisse zeigte; der CAT-Score war signifikant niedriger. Sie sehen dies als Option, wenn Zentrumstherapie nicht möglich ist.

Kernaussagen

  • CAT-Score signifikant niedriger: MD −1,29 (95 %-KI −2,39 bis −0,20)
  • 6MWD, mMRC, SGRQ und Hospitalisierung ohne signifikanten Unterschied
  • Mobile App-basierte Rehabilitation kann eine Option sein, wenn Zentrumstherapie nicht möglich ist

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

At a glance

Metaanalyse in JMIR mHealth and uHealth, published online on 2024-01-04. Written by Chiwook Chung and 3 co-authors. Institution: Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. Major MEDLINE topics: Mobile Applications, Pulmonary Disease, Chronic Obstructive. Cited 48 times so far (Crossref); 50 references. The full text is freely available in PubMed Central.

Auf einen BlickAbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Background

Pulmonary rehabilitation is well known to improve clinical symptoms (including dyspnea), quality of life, and exercise capacity in patients with chronic obstructive pulmonary disease (COPD). However, researchers have reported difficulties in practicing center-based pulmonary rehabilitation. Recently, mobile app–based pulmonary rehabilitation has become available in clinical practice. We investigated the clinical outcomes of mobile app–based pulmonary rehabilitation in patients with COPD.

Objective

The objective of our study was to evaluate the clinical efficacy of mobile app–based pulmonary rehabilitation versus conventional center-based pulmonary rehabilitation for patients with COPD, using a systematic review and meta-analysis.

Methods

A systematic search of the literature published between January 2007 and June 2023 was performed, using the PubMed, Embase, Cochrane, and CINAHL databases to identify relevant randomized controlled trials involving patients with COPD. Pulmonary rehabilitation programs needed to provide an exercise program on a smartphone app. Study outcomes, including exercise capacity, symptom scores, quality of life, and hospitalization, were evaluated. The meta-analysis evaluated mean differences in 6-minute walk test distances (6MWDs), COPD Assessment Test (CAT) scores, modified Medical Research Council (mMRC) dyspnea scale scores, St. George Respiratory Questionnaire (SGRQ) scores, and risk ratios for hospitalization resulting from disease exacerbation.

Results

Of the 1173 screened studies, 10 were included in the systematic review and 9 were included in the meta-analysis. Further, 6 studies were multicenter studies. There were a total of 1050 participants, and most were aged ≥65 years. There were discrepancies in the baseline participant characteristics, smartphone apps, interventions, and study outcomes among the included studies. In the meta-analysis, 5 studies assessed 6MWDs (mean difference 9.52, 95% CI −3.05 to 22.08 m), 6 studies assessed CAT scores (mean difference −1.29, 95% CI −2.39 to −0.20), 3 studies assessed mMRC dyspnea scale scores (mean difference −0.08, 95% CI −0.29 to 0.13), 2 studies assessed SGRQ scores (mean difference −3.62, 95% CI −9.62 to 2.38), and 3 studies assessed hospitalization resulting from disease exacerbation (risk ratio 0.65, 95% CI 0.27-1.53). These clinical parameters generally favored mobile app–based pulmonary rehabilitation; however, a statistically significant difference was noted only for the CAT scores ( P =.02).

Conclusions

Despite some discrepancies in the baseline participant characteristics and interventions among studies, mobile app–based pulmonary rehabilitation resulted in favorable exercise capacity, symptom score, quality of life, and hospitalization outcomes when compared with conventional pulmonary rehabilitation. In the meta-analysis, the CAT scores of the mobile app–based pulmonary rehabilitation group were significantly lower than those of the control group ( P =.02). In real-world practice, mobile app–based pulmonary rehabilitation can be a useful treatment option when conventional center-based pulmonary rehabilitation is not feasible.

Subjects

MeSH terms (MEDLINE)

Mobile ApplicationsPulmonary Disease, Chronic ObstructiveHumansQuality of LifeTreatment OutcomeDisease ProgressionDyspnea

Author keywords

6-minute walk test distance6MWDCATCOPDCOPD Assessment TestPRISMASGRQSt. George Respiratory Questionnairechronic obstructive pulmonary diseaseclinical efficacyexacerbationmHealthmMRCmobile appmobile application

Authors and institutions

  • Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Department of Pulmonary and Critical Care Medicine, Gangneung Asan Hospital, University of Ulsan College of Medicine, Gangneung, Republic of Korea.
  • Division of Breast Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Department of Preventive Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.

ORCID profiles: Chiwook Chung, Jong Won Lee, Sei Won Lee, Min-Woo Jo

Cite

APA

Chung, C., Lee, J. W., Lee, S. W., & Jo, M. W. (2024). Clinical Efficacy of Mobile App–Based, Self-Directed Pulmonary Rehabilitation for Patients With Chronic Obstructive Pulmonary Disease: Systematic Review and Meta-Analysis. JMIR mHealth and uHealth, 12, e41753-e41753. https://doi.org/10.2196/41753

Vancouver

Chung C, Lee JW, Lee SW, Jo MW. Clinical Efficacy of Mobile App–Based, Self-Directed Pulmonary Rehabilitation for Patients With Chronic Obstructive Pulmonary Disease: Systematic Review and Meta-Analysis. JMIR mHealth and uHealth. 2024;12:e41753-e41753. doi:10.2196/41753

BibTeX
@article{Chung2024,
  author = {Chung, Chiwook and Lee, Jong Won and Lee, Sei Won and Jo, Min-Woo},
  title = {Clinical Efficacy of Mobile App–Based, Self-Directed Pulmonary Rehabilitation for Patients With Chronic Obstructive Pulmonary Disease: Systematic Review and Meta-Analysis},
  journal = {JMIR mHealth and uHealth},
  year = {2024},
  volume = {12},
  pages = {e41753--e41753},
  doi = {10.2196/41753}
}
Start for free →